FDA Slaps Extreme Caution Warning On Tricyclic Anti-Depressant, Norpramin

Although Norpramin is not much used these days, the FDA and Sanofi-Adventis today announced a Dear Doctor letter would be sent out detailing very serious problems with the tricyclic’s use in some people.

“The new safety information states that extreme caution should be used when this drug is given to patients who have a family history of sudden death, cardiac dysrhythmias, and cardiac conduction disturbances; and that seizures precede cardiac dysrhythmias and death in some patients.”

That says it all.

Go to Source

Related posts:

  1. Doctors On CNN, Fox News Criticize Long-Term Anti-Depressant Use
  2. Two Studies: Mom’s Anti-Depressant Tied To Newborns’ Health Problems
  3. Little-Known TC-5214 Touted As Effective Anti-Depressant Despite Little Evidence
  4. Tragic Anti-Depressant Withdrawal, Murder Case In UK
  5. LA Times Actually Writes About Anti-Depressant Withdrawal Problems

Leave a Reply

 
Special Offers
Blogroll

Pages
Tags